• Profound Medical posted an 8-K announcing expanded visibility for its MRI-guided TULSA Procedure at the Society of Robotic Surgery meeting on July 23-26, 2026.
• Physician presentations will include real-world registry outcomes plus CAPTAIN randomized trial safety results comparing TULSA with radical prostatectomy.
• Management is also scheduled to join an SRS investor session on July 22, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Profound Medical Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001171843-26-004654), on July 15, 2026, and is solely responsible for the information contained therein.